Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.
Seeking Alpha

Clinician Use of Clover Assistant is Associated with Significant Improvement in the Early Identification and Management of Chronic Kidney Disease

FRANKLIN, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis and Progression of Chronic Kidney ...
Zacks Investment Research on MSN

Here's why you should retain Clover stock in your portfolio for now

Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This optimism is primarily driven by its technology-first care model, as ...